Ma Ze-jun, Chen Rui, Ren Hui-Zhu, Guo Xin, Guo Jun, Chen Li-ming
Collaborative Innovation Center of Tianjin for Medical Epigenetics, Key Laboratory of Hormone and Development (Ministry of Health), Metabolic Disease Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300070, China.
J Diabetes Res. 2014;2014:549747. doi: 10.1155/2014/549747. Epub 2014 May 8.
Many studies have assessed the association between eNOS-4b/a polymorphism and the risk of diabetic retinopathy (DR) among type 2 diabetic subjects. However, the results are inconsistent. In order to derive a more precise estimation of the association, a meta-analysis was conducted. Fifteen studies with 3, 183 cases and 3, 410 controls were enrolled by searching the databases of Pubmed, Embase, China National Knowledge Infrastructure (CNKI), and Chinese Wanfang Database. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. The main analysis indicated no significant association between eNOS-4b/a polymorphism and the risk of DR in overall population [allelic model: OR = 0.94 (0.79-1.11); additive model: OR = 0.91 (0.73-1.14); recessive model: OR = 1.01 (0.81-1.25); dominant model: OR = 0.91 (0.75-1.09)]. Subgroup analysis by ethnicity also indicated no significant association. In conclusion, the current meta-analysis did not observe any association between the polymorphism of eNOS 4b/a and the risk of DR among type 2 diabetic subjects. However, larger well-designed studies are required to confirm this finding.
许多研究评估了2型糖尿病患者中内皮型一氧化氮合酶(eNOS)4b/a多态性与糖尿病视网膜病变(DR)风险之间的关联。然而,结果并不一致。为了更精确地估计这种关联,进行了一项荟萃分析。通过检索PubMed、Embase、中国国家知识基础设施(CNKI)和中国万方数据库,纳入了15项研究,共3183例病例和3410例对照。计算了汇总比值比(OR)及95%置信区间(CI)。主要分析表明,在总体人群中,eNOS 4b/a多态性与DR风险之间无显著关联[等位基因模型:OR = 0.94(0.79 - 1.11);加性模型:OR = 0.91(0.73 - 1.14);隐性模型:OR = 1.01(0.81 - 1.25);显性模型:OR = 0.91(0.75 - 1.09)]。按种族进行的亚组分析也表明无显著关联。总之,当前的荟萃分析未观察到2型糖尿病患者中eNOS 4b/a多态性与DR风险之间存在任何关联。然而,需要更大规模的精心设计的研究来证实这一发现。